Associate Professor Ki-Bum Lee has developed patent-pending technology that may overcome one of the critical barriers to harnessing the full therapeutic potential of stem cells.
One of the major challenges facing researchers interested in regenerating cells and growing new tissue to treat debilitating injuries and diseases such as Parkinson’s disease, heart disease, and spinal cord trauma, is creating an easy, effective, and non-toxic methodology to control differentiation into specific cell lineages. Lee and colleagues at Rutgers and Kyoto University in Japan have invented a platform they call NanoScript, an important breakthrough for researchers in the area of gene expression. Gene expression is the way information encoded in a gene is used to direct the assembly of a protein molecule, which is integral to the process of tissue development through stem cell therapeutics.
Stem cells hold great promise for a wide range of medical therapeutics as they have the ability to grow tissue throughout the body. In many tissues, stem cells have an almost limitless ability to divide and replenish other cells, serving as an internal repair system.
Transcription factor (TF) proteins are master regulators of gene expression. TF proteins play a pivotal role in regulating stem cell differentiation. Although some have tried to make synthetic molecules that perform the functions of natural transcription factors, NanoScript is the first nanomaterial TF protein that can interact with endogenous DNA. ACS Nano, a publication of the American Chemical Society (ACS), has published Lee’s research on NanoScript. The research is supported by a grant from the National Institutes of Health (NIH).
“Our motivation was to develop a highly robust, efficient nanoparticle-based platform that can regulate gene expression and eventually stem cell differentiation,” said Lee, who leads a Rutgers research group primarily focused on developing and integrating nanotechnology with chemical biology to modulate signaling pathways in cancer and stem cells. “Because NanoScript is a functional replica of TF proteins and a tunable gene-regulating platform, it has great potential to do exactly that. The field of stem cell biology now has another platform to regulate differentiation while the field of nanotechnology has demonstrated for the first time that we can regulate gene expression at the transcriptional level.”
NanoScript was constructed by tethering functional peptides and small molecules called synthetic transcription factors, which mimic the individual TF domains, onto gold nanoparticles.
“NanoScript localizes within the nucleus and initiates transcription of a reporter plasmid by up to 30-fold,” said Sahishnu Patel, Rutgers Chemistry graduate student and co-author of the ACS Nano publication. “NanoScript can effectively transcribe targeted genes on endogenous DNA in a nonviral manner.”
The Latest on: Stem Cell Therapeutics
via Google News
The Latest on: Stem Cell Therapeutics
- Innovative technique developed to destroy cancerous kidney cellson April 14, 2021 at 7:40 am
An innovative new technique that encourages cancer cells in the kidneys to self-destruct could revolutionize the treatment of the disease, a new study in the journal Pharmaceutics reports.
- Agenus Doses First Cancer Patient with iNKT Cell Therapyon April 14, 2021 at 5:40 am
Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines designed to activate immune response to cancers and ...
- Coya Therapeutics™ Announces the Appointment Ofon April 14, 2021 at 4:48 am
One of your neighbors posted in Business. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- PsiOxus and bluebird bio Present Novel Data Combining PsiOxus T-SIGn Platform with CAR-T Therapy to Clear Primary Tumors and Metastaseson April 14, 2021 at 4:00 am
PsiOxus Therapeutics, Ltd. (PsiOxus), a clinical stage oncology company re-programming the tumor microenvironment to overcome the central challenge ...
- AgenTus’ Immune Cell Therapy In Patients With COVID-19 And Canceron April 13, 2021 at 6:01 pm
COVID-19 has caused a global healthcare crisis and cancer persists as a leading cause of death worldwide. Could cell therapy be the answer for both?
- Gene therapy may offer a new approach to preserving vision in people with retinitis pigmentosaon April 13, 2021 at 4:38 pm
A gene therapy protects eye cells in mice with a rare disorder that causes vision loss, especially when used in combination with other gene therapies, shows a study published today in eLife. The ...
- Cell Therapy Market Size to Hit $48.11 Billion, at 25.6% CAGR, by 2027on April 13, 2021 at 7:40 am
Technological advancements in the medical field, rise in number of cell therapies in clinical studies, and increase in adoption of regenerative medicines fuel the growth of the market for global cell ...
- A new international consortium to promote stem cell-based therapy for Huntington's diseaseon April 9, 2021 at 8:47 am
The Stem Cells for Huntington's Disease (SC4HD) is a new international consortium created to promote advanced therapy medicinal product (ATMP) through cell transplantation studies on Huntington's ...
- Stem Cells Market Size 2021: Market Share, Top Companies report covers are Osiris Therapeutics,NuVasive,Chiesi Pharmaceuticalon April 8, 2021 at 11:01 pm
Stem Cells Market “ Size, Status and Market Insights 2021, ,Stem Cells Market By Type (Allogeneic,Autologous,,), ...
- New stem cell therapy shows promise to prevent diabetes-related amputationson April 7, 2021 at 3:58 pm
According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the ...
via Bing News